U.S. scientists find treatment for rare genetic skin disorder

LOS ANGELES, June 1 (Xinhua) -- Researchers at the U.S. National Institutes of Health (NIH) have identified genomic variants that cause a rare and severe inflammatory skin disorder, known as disabling pansclerotic morphea, and have found a potential treatment.

Scientists discovered that people with the disorder have an overactive version of a protein called STAT4, which regulates inflammation and wound healing.